Alphadyne Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Alphadyne Asset Management's REGN Position: Q2 2026 in Review
Alphadyne Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 94% in Q2 2026, selling an estimated $481K and leaving 48 shares worth $29.9K. The position accounts for ﹤0.01% of the portfolio, ranked #839.
Alphadyne Asset Management first reported a position in REGN in Q3 2023 and has held it in 4 quarters since. The position peaked at $583K in Q1 2026. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Alphadyne Asset Management held 48 shares of Regeneron Pharmaceuticals worth $29.9K as of Q2 2026.
- Alphadyne Asset Management sold 706 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $481K.
- Regeneron Pharmaceuticals made up ﹤0.01% of Alphadyne Asset Management's portfolio in Q2 2026, its #839 holding.
- Alphadyne Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2023 and has held it in 4 quarters since.
- Alphadyne Asset Management's Regeneron Pharmaceuticals position peaked at $583K in Q1 2026.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Alphadyne Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.